Cite
Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity.
MLA
Xiao Ma, et al. “Retinoid X Receptor Alpha Is a Spatiotemporally Predominant Therapeutic Target for Anthracycline-Induced Cardiotoxicity.” Science Advances, vol. 6, no. 5, Jan. 2020, pp. 1–14. EBSCOhost, https://doi.org/10.1126/sciadv.aay2939.
APA
Xiao Ma, Ping Zhu, Yonghe Ding, Hong Zhang, Qi Qiu, Dvornikov, A. V., Zheng Wang, Maengjo Kim, Yong Wang, Lowerison, M., Yue Yu, Norton, N., Herrmann, J., Ekker, S. C., Hsiai, T. K., Xueying Lin, & Xiaolei Xu. (2020). Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity. Science Advances, 6(5), 1–14. https://doi.org/10.1126/sciadv.aay2939
Chicago
Xiao Ma, Ping Zhu, Yonghe Ding, Hong Zhang, Qi Qiu, Alexey V. Dvornikov, Zheng Wang, et al. 2020. “Retinoid X Receptor Alpha Is a Spatiotemporally Predominant Therapeutic Target for Anthracycline-Induced Cardiotoxicity.” Science Advances 6 (5): 1–14. doi:10.1126/sciadv.aay2939.